This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
3-MeO-PCE: Difference between revisions
>Tracer |
>Psyched m typo |
||
| Line 34: | Line 34: | ||
*'''[[Effect::Spontaneous physical sensations]]''' - The body high of this compound can be described in terms of its style variations as a motionless, constant, sharp, all-encompassing, euphoric general activation of nerve endings across the body. This feels halfway between the same sensations induced by [[3-MeO-PCP]] and [[O-PCE]] and disappears at higher doses due to the disconnecting and anesthetic effects it produces. | *'''[[Effect::Spontaneous physical sensations]]''' - The body high of this compound can be described in terms of its style variations as a motionless, constant, sharp, all-encompassing, euphoric general activation of nerve endings across the body. This feels halfway between the same sensations induced by [[3-MeO-PCP]] and [[O-PCE]] and disappears at higher doses due to the disconnecting and anesthetic effects it produces. | ||
*'''[[Effect::Physical euphoria]]''' - At lower to moderate dosages, the sensation itself can be described as feelings of physical comfort, warmth and euphoria which spreads throughout the body. However, at heavier dosages, this sensation becomes neutral or potentially uncomfortable in terms of its enjoyability. | *'''[[Effect::Physical euphoria]]''' - At lower to moderate dosages, the sensation itself can be described as feelings of physical comfort, warmth and euphoria which spreads throughout the body. However, at heavier dosages, this sensation becomes neutral or potentially uncomfortable in terms of its enjoyability. | ||
*'''[[Effect::Bodily control enhancement]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine | *'''[[Effect::Bodily control enhancement]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine motor control. | ||
*'''[[Effect::Tactile enhancement]]''' & '''[[Effect::Tactile suppression]]''' - At lower dosages, this compound tends to induce tactile enhancements. At higher dosages, this enhancement shifts towards tactile suppressions and [[pain relief|anesthesia]]. | *'''[[Effect::Tactile enhancement]]''' & '''[[Effect::Tactile suppression]]''' - At lower dosages, this compound tends to induce tactile enhancements. At higher dosages, this enhancement shifts towards tactile suppressions and [[pain relief|anesthesia]]. | ||
*'''[[Effect::Motor control loss]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine. motor control. | *'''[[Effect::Motor control loss]]''' - At lower dosages this compound typically induces enhancements in bodily control. At higher dosages, this enhancement shifts towards losses in gross and fine. motor control. | ||